Abstract:Background: Neurofibromatosis Type 1 (NF1) is a congenital neurocutaneous disorder. As NF1 is incurable and presents with a wide range of physical and mental symptoms, knowledge of neurocognitive and behavioral functioning can be an important aid in understanding their functional impact, and developing treatment options. To date, studies in children with NF1 have shown dysfunction in several domains, but much less is known about cognition and behavior in adults with NF1. The present study describes the neuropsychological phenotype of adults with NF1 based on comprehensive clinical examination of cognition and behavior across multiple functions. Methods: Participants were 62 adults with NF1 (mean age 38.2 years; SD 13.4). All underwent individual clinical neuropsychological assessment at the Center of Excellence for Neuropsychiatry as part of regular care. Scores on all individual measures were standardized into z-scores based on the corresponding normative group data. The proportions of mean z-scores in the NF1 study group were calculated according to cut-off points (±1 to ±1.5 SD; > ±1.5 SD) and compared to the expected proportions in the normal population distribution. Cognition and behavior was tested against population means constructed by bootstrapping. Results: Performance on the cognitive measures oral reading speed, visuospatial copying, visuospatial immediate recall, visual learning/imprinting, and visual memory immediate recall in the NF1 group were lower than normative means. The behavioral measures indicated higher levels of dysfunction, including psychopathology. The proportions of the NF1 study group with lower cognitive performance and higher levels of behavioral dysfunction were larger than in the normal population distributions. In addition, domain-level results revealed that intelligence, attention/speed, memory, and social cognition reflect cognitive dysfunction. Moreover, levels of emotion perception problems, experienced executive dysfunction, internalizing psychopathology (e.g., anxiety, depression), and severe fatigue were significantly higher compared to the simulated population sample. The mean level of emotion regulation (coping strategies) did not differ significantly from the population. Conclusion: Identified cognitive and behavioral dysfunction in multiple domains indicates high vulnerability in adults with NF1 and underscores the importance of individualized neuropsychological assessment and treatment. Further research on the relationships between cognition and behavior (including fatigue) in NF1 is warranted.

Genotype–phenotype Correlations of Neurofibromatosis Type 1: a Cross-Sectional Study from a Large Chinese Cohort

Genotype-Phenotype Correlations in Neurofibromatosis Type 1: A Single-Center Cohort Study

Molecular Characterization of NF1 and Neurofibromatosis Type 1 Genotype-Phenotype Correlations in a Chinese Population

Clinical and Molecular Characteristics of Thirty NF1 Variants in Chinese Patients with Neurofibromatosis Type 1

Clinical Presentation And Novel Pathogenic Variants Among 68 Chinese Neurofibromatosis 1 Children

Breast Cancer Risk and Germline Genomic Profiling of Women with Neurofibromatosis Type 1 Who Developed Breast Cancer.

Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1

Five Novel NF1 Gene Pathogenic Variants in 10 Different Chinese Families with Neurofibromatosis Type 1

Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients

A Chinese Collaborative Model for Accelerating Neurofibromatosis Type 1-Associated Research

Genetic Analysis and Prenatal Diagnosis of a Sporadic Family with Neurofibromatosis Type 1

Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes.

Skewed allele-specific expression of the NF1 gene in normal subjects: A possible mechanism for phenotypic variability in neurofibromatosis type 1

Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use

[Several suggestions for improving diagnosis and management of patients with neurofibromatosis type 1]

Correlation between large rearrangements and patient phenotypes in NF1 deletion syndrome: an update and review

Genotypes and clinical intervention of patients with neurofibromatosis type 1 associated dystrophic scoliosis

Evaluation and Factors of Quality of Life Among Patients With Neurofibromatosis Type 1-Associated Craniofacial Plexiform Neurofibromas.

Skewed Allele-Specific Expression of the<i>NF1</i>Gene in Normal Subjects

Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype

Cognition and behavior in adults with neurofibromatosis type 1